Abiochem Picks up ￥300 Million in Series C Funding

(VCBeat) Apr. 30, 2021 -- Abiochem Biotechnology Co., Ltd. ("Abiochem") recently raised nearly 300 million yuan in a Series C financing, led by Temasek Holdings. The funds raised in this round will be mainly used for Abiochem's research and development of products in synthetic biology and the construction of a new production base in Chongqing. The injection of the investment will further improve the leading strength in the field of bio-intelligent manufacturing.

Abiochem is a high-tech company with leading genetic & enzyme engineering technologies. The company studies and develops new biocatalysis and synthetic biology processes, and applies them in commercial-scale production. Their biological processes have been applied in pharmaceutical, health care, agrochemical areas, and they are making contributions for the popularization and application of green chemistry.

After several years of hard work, the professional R&D team of Abiochem established one of the biggest enzyme library in China, and accumulated rich experiences on enzyme screening, modification, determinate evolution, fermentation, immobilization and the commercialization of biocatalysis reactions. With all these experiences, Abiochem is devoted to establishing a professional platform providing CRO & CMO services focusing on biocatalysis technologies, and it'll try its best to be a leading biocatalysis company in the world.

Since its establishment in 2015, Abiochem has been frequently invested by capital due to its rapid development and brilliant performance. Earlier investors Highlight Capital, Huatai Zijin, and Binghong Capital have continuously injected money into Abiochem. Temasek has also participated this time, bringing total financing to nearly 700 million yuan. In addition, we learned that Abiochem is currently in the guidance period for IPO, and plans to apply for IPO on the Science and Technology Innovation Board.

Incorporated in 1974, Temasek is an investment company based in Singapore. Temasek's portfolio covers a broad spectrum of sectors: telecommunications, media & technology; financial services; transportation & industrials; consumer & real estate; life sciences & agriculture; energy & resources.